Profit taking weighs down Eyegate Pharmaceuticals By: MarketMinute.com Stock News February 22, 2017 at 17:00 PM EST Profit taking weighed down shares of Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG) $1.17 to close at $2.53. Related Stocks: Ab Corporate Bond ETF